Printer Friendly
The Free Library
19,607,053 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ESTECH Announces COBRA(R) Adhere(TM) Radio Frequency Ablation Device Receives First Ever CE Indication for Surgical Treatment of Atrial Fibrillation (AF).


BARCELONA, Spain -- ESTECH COBRA(R) Products Receive FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 Marketing Clearance: COBRA(R) Accessory Intended for Use in Atrial Fibrillation Treatment

At the European Association of Cardiothoracic Surgery (EACTS EACTS European Association for Cardio-Thoracic Surgery ) Conference ESTECH (Danville, CA) announced that they have received European and US regulatory clearances to market ESTECH COBRA(R) products that are used surgically to treat Atrial Fibrillation (AF). Over five million people in the US and Europe are affected by AF. This heart disease is associated with serious complications and is the leading cause of stroke. ESTECH's COBRA(R) line of products are the first ablation devices available that have received clearance to be marketed specifically for AF.

Ray Bertolero, ESTECH Vice President and co-founder, announced the regulatory clearances today in a large scientific conference of cardiac surgeons saying, "ESTECH's COBRA(R) technology has proven clinical results in treating AF." He went on to say, "The new COBRA devices, which are now available, will offer new treatment options to a significant number of current AF patients."

The ESTECH COBRA(R), COBRA(R) Adhere(TM) XL and the COBRA(R) Bipolar Pacing Probe have recently received US FDA 510K marketing clearance. The COBRA(R) Adhere(TM) Surgical System received the CE mark with an indication for treatment of AF. The COBRA(R) Adhere(TM) is used by surgeons to make lesions on the heart that block the electrical impulses that cause AF. The COBRA(R) Adhere(TM) XL will enable a minimally invasive technique to treat AF. The COBRA(R) Bipolar Pacing Probe is the first RFA RFA right frontoanterior (position of the fetus).
Radiofrequency ablation (RFA)
A procedure in which radiofrequency waves are used to destroy blood vessels and tissues.

Mentioned in: Prenatal Surgery
 accessory in the US and Europe to be intended for the treatment of cardiac arrhythmias. It provides a means for immediately evaluating the effectiveness of AF treatment procedures.

COBRA(R) technology uses a unique intelligent temperature based system that provides both optimal and reproducible results by regulating the RF energy. Other systems offered by AtriCure (ATRC ATRC Adaptive Technology Resource Centre (Canada)
ATRC Assistive Technology Resource Center
ATRC Aegis Training and Readiness Center
ATRC Advanced Television Research Consortium
ATRC Alien Terrorist Removal Court
ATRC Against the Rest Crew
), Medtronic (MDT MDT
abbr.
Mountain Daylight Time


MDT (in the US and Canada) Mountain Daylight Time

MDT n abbr (US) (= mountain daylight time) →
) and Guidant (GDT GDT Global Descriptor Table
GDT Geographic Data Technology Inc.
GDT Gas Discharge Tube (energy, electrotechinical and electronics)
GDT Getting Things Done
GDT Geometric Dimensioning & Tolerancing
GDT Ground Data Terminal
) do not have this advanced energy regulation technology.

About ESTECH

ESTECH headquartered in Danville, CA offers tools for least invasive techniques and traditional approaches to the procedures that cardiac surgeons do every day -- coronary artery bypass Coronary artery bypass
Surgical procedure to reroute blood around a blocked coronary artery.

Mentioned in: Heart Failure

coronary artery bypass,
n
, valve Surgery, atrial ablation and surgical treatment of congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. .

Note to Editors: ESTECH, Inc. and "Cobra" are trademarks owned by or licensed to Endoscopic Technologies, Inc.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 28, 2005
Words:380
Previous Article:NetWolves Receives Notification from Nasdaq of Extension to Meet the Minimum Bid Requirement.
Next Article:3Si Holdings announces a Definitive Agreement to Merge with eSPG.



Related Articles
Cardima Announces U.S. Market Launch of Surgical Ablation System; First Procedure Successfully Performed at Lenox Hill Hospital.
Cardima Surgical Ablation System Presented at 'Controversies in Adult Cardiac Surgery III' Educational Program Santa Monica, CA.
Cardima Receives CE Mark Clearance for the INTELLITEMP Radio Frequency Energy Management Device.
Cardima Receives CE Mark Clearance for the Surgical Ablation System.
ESTECH Announces David K. Swanson, PhD, as Chief Technology Officer.
Chicago Area Surgeon Conducts First Minimally Invasive Stand Alone Atrial Fibrillation (AF) Procedure Using the ESTECH Cobra(R) Adhere System.
Florida Surgeon Completes Successful Series of Patients Using New Minimally Invasive Treatment for Atrial Fibrillation (AF).
ESTECH Launches the COBRA Adhere XL, a New Cardiac Ablation Product Offering an Alternative Treatment With Proven Safety and Effectiveness.
ESTECH Launches AFfirm(TM), First Cardiac Surgery Product Indicated for Use in the Treatment of Atrial Fibrillation; Innovative Device Provides Real...
ESTECH COBRA(R) Devices and Patented "Box Lesion" Acknowledged as Key Elements in Successful Cardiac Ablation at Recent American Association for...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles